![]() |
市場調查報告書
商品編碼
2149560
創傷護理和先進敷料技術市場預測至2034年—按產品類型、傷口類型、分銷管道、最終用戶和地區分類的全球分析Wound Care & Advanced Dressing Technologies Market Forecasts to 2034 - Global Analysis By Product Type, Wound Type, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 預測,全球創傷護理和先進敷料技術市場預計將在 2026 年達到 134 億美元,在預測期內以 6.3% 的複合年成長率成長,到 2034 年達到 219 億美元。
創傷護理和先進敷料技術包括用於保護傷口、促進組織修復、控制傷口滲液、降低感染風險以及創造適宜癒合環境的專用解決方案。該市場涵蓋利用親水膠體、水凝膠、泡沫、藻酸鹽、抗菌劑、膠原蛋白和數位技術的敷料技術。這些先進解決方案擴大應用於慢性傷口、手術傷口、燒燙傷、糖尿病潰瘍和壓瘡的治療。其研發重點在於加速傷口癒合、提高病患舒適度、支持感染預防,並實現醫院、診所和其他醫療機構更有效的傷口管理。
根據國際糖尿病聯盟(IDF)的數據,到2024年,全球20至79歲成年人中將有5.89億人患有糖尿病,佔該年齡層成年人口的11.1%。 IDF預測,到2050年,這一數字將達到8.525億。糖尿病與足部潰瘍和其他慢性傷口密切相關,凸顯了創傷護理產品和先進敷料技術的必要性。
慢性傷口盛行率增加
慢性傷口負擔日益加重,推動了對創傷護理和先進敷料技術的需求。糖尿病、肥胖症和血管疾病的盛行率不斷上升,以及身體機能的下降,導致糖尿病潰瘍、靜脈傷口和壓瘡的發生率增加。由於這些疾病通常需要長期治療,醫療機構對能夠調節傷口濕潤環境、控制傷口滲出液、預防感染和促進組織修復的專用敷料的需求日益成長。因此,泡棉敷料、親水膠體敷料、藻酸鹽敷料、抗菌敷料和膠原蛋白敷料的廣泛應用,促進了市場成長。
先進創傷護理產品高成本
先進的創傷護理方案價格相對昂貴,這可能會限制其與傳統敷料相比的普及。抗菌產品、膠原蛋白敷料、特殊泡棉敷料和其他技術先進的解決方案會增加醫療機構和患者的成本。保險報銷不足和醫院預算限制也可能進一步阻礙其應用。因此,面臨財務壓力的醫療機構可能仍依賴傳統敷料,尤其是在治療大量患者或管理需要長期照護的慢性傷口時。
擴大居家創傷護理
居家傷口管理的日益普及為先進的傷口敷料技術帶來了巨大的發展機會。門診就診量的增加、老年人口的成長、慢性傷口的持續存在以及縮短住院時間的努力,都促使部分傷口護理轉移到患者家中。專為方便使用、提升病患舒適度、維持體液平衡和控制滲出液而設計的專用敷料可以促進此轉變。此外,遠端醫療諮詢和遠端傷口監測有助於臨床醫生監督治療,從而為先進的創傷護理解決方案在居家醫療的更廣泛應用創造了機會。
與傳統療法和替代療法的競爭
先進的創傷護理技術面臨來自傳統產品和替代療法的競爭。由於紗布、繃帶和傳統敷料易於獲取且價格通常更實惠,尤其是在預算緊張的醫療機構中,因此它們仍然被廣泛使用。其他方法,例如負壓傷口治療、生物材料、局部治療和特殊干預措施,也在爭奪臨床應用和醫療支出。因此,既有的治療實務和價格壓力可能會減緩醫療機構過渡到新型先進敷料解決方案的速度。
新冠疫情對創傷護理和先進敷料技術市場產生了重大影響,手術延期、常規門診就診量減少以及醫療資源重新分配以應對疫情,都加劇了這一趨勢。運輸限制和供應鏈挑戰也導致生產和分銷網路中斷。儘管如此,創傷護理對於慢性病患者、創傷患者以及需要持續治療的患者仍然至關重要。隨著醫療機構逐步恢復正常運營,市場也逐漸復甦,這主要得益於遠距遠端醫療和居家醫療的普及,並催生了新的傷口監測和管理方法。
在預測期內,高級傷口敷料細分市場預計將佔據最大的市場佔有率。
預計在預測期內,高級傷口敷料將佔據最大的市場佔有率,因為它能提供多樣化的解決方案,滿足各種傷口類型和臨床需求。其功能包括維持適當的濕度、控制傷口滲液、降低感染風險、促進組織修復。這些敷料廣泛用於慢性傷口、手術傷口、燒燙傷、糖尿病潰瘍、壓瘡等。種類繁多的專用敷料以及持續的技術進步,確保了它們在醫院、門診機構和家庭創傷護理環境中的持續應用。
在預測期內,居家醫療領域預計將呈現最高的複合年成長率。
在預測期內,隨著傷口管理日益轉向更便利、以患者為中心的居家護理,居家醫療領域預計將呈現最高的成長率。慢性傷口盛行率上升、人口老化、住院時間縮短以及對更經濟實惠的照護的需求,都是推動這項轉變的因素。先進的傷口敷料透過控制濕度、滲出液、預防感染和加速癒合,能夠實現有效的居家護理。此外,遠端醫療服務和遠距監測技術的日益普及,正在改善臨床監管,並為先進創傷護理產品在居家醫療的廣泛應用創造了有利條件。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其發達的醫療保健體系、創新醫療解決方案的廣泛應用以及對慢性傷口護理的巨大需求。該地區對糖尿病、血管疾病、壓瘡和其他複雜傷口相關治療的需求尤其旺盛。專業創傷護理機構、先進療法和成熟治療方案的普及推動了這些產品的廣泛應用。已發表的研究表明,北美是全球先進創傷護理產品和技術最大的區域市場。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於醫療保健體系的改善、外科手術數量的增加、慢性傷口病例的增多以及醫療保健投資的擴大。中國、印度和日本等市場正透過改善醫療保健服務可近性和提高先進傷口護理解決方案的使用率來支持區域發展。人口老化和慢性病的盛行率上升也進一步刺激了對專業產品的需求。此外,持續的技術創新也促進了先進創傷護理技術在全部區域廣泛應用。
According to Stratistics MRC, the Global Wound Care & Advanced Dressing Technologies Market is accounted for $13.4 billion in 2026 and is expected to reach $21.9 billion by 2034 growing at a CAGR of 6.3% during the forecast period. Wound Care & Advanced Dressing Technologies cover specialized solutions that safeguard wounds, facilitate tissue repair, control wound fluid, reduce infection risks, and create suitable healing conditions. The market includes hydrocolloid, hydrogel, foam, alginate, antimicrobial, collagen, and digitally enabled dressing technologies. These advanced solutions are increasingly used for managing chronic and surgical wounds, burns, diabetic ulcers, and pressure-related injuries. Their development focuses on accelerating healing, improving patient comfort, supporting infection prevention, and enabling more effective wound management in hospitals, clinics, and other healthcare environments.
According to the International Diabetes Federation (IDF), 589 million adults aged 20-79 were living with diabetes globally in 2024, representing 11.1% of adults in this age group. The IDF projects this number to reach 852.5 million by 2050. Diabetes is closely associated with foot ulcers and other chronic wounds, supporting the need for wound-care products and advanced dressing technologies.
Rising prevalence of chronic wounds
The growing burden of chronic wounds is supporting demand for Wound Care & Advanced Dressing Technologies. Rising rates of diabetes, obesity, vascular diseases, and limited mobility are increasing the occurrence of diabetic ulcers, venous wounds, and pressure injuries. Because these conditions frequently require extended treatment, healthcare facilities are turning to specialized dressings that regulate moisture, manage wound exudate, protect against infection, and support tissue repair. Increasing utilization of foam, hydrocolloid, alginate, antimicrobial, and collagen dressings is therefore contributing to market expansion.
High cost of advanced wound care products
The relatively high price of advanced wound care solutions can limit their widespread adoption compared with traditional dressings. Antimicrobial products, collagen dressings, specialized foams, and other technologically advanced solutions may increase treatment expenses for healthcare providers and patients. Inadequate reimbursement and restricted hospital budgets can create additional barriers to adoption. Consequently, healthcare facilities operating under financial pressure may continue relying on conventional dressings, particularly when treating numerous patients or managing chronic wounds that require extended periods of care.
Expansion of home-based wound care
Growing adoption of home-based wound management offers significant opportunities for advanced dressing technologies. Greater use of outpatient services, increasing numbers of older adults, persistent chronic wounds, and efforts to shorten hospital stays are shifting some wound treatment toward patients' homes. Specialized dressings designed for convenient application, patient comfort, moisture balance, and exudate control can facilitate this transition. In addition, telehealth consultations and remote wound monitoring can help clinicians supervise treatment, creating opportunities for broader adoption of advanced wound care solutions in home healthcare.
Competition from conventional and alternative treatment methods
Advanced wound care technologies face competition from established conventional products and alternative treatment methods. Basic gauze, bandages, and traditional dressings continue to be commonly used because they are accessible and generally more affordable, particularly in budget-constrained healthcare settings. Other approaches, including negative pressure wound therapy, biological materials, topical therapies, and specialized interventions, also compete for clinical adoption and healthcare expenditure. Established treatment habits and pricing pressures can consequently reduce the pace at which healthcare providers shift toward newer advanced dressing solutions.
COVID-19 significantly affected the Wound Care & Advanced Dressing Technologies Market through postponed surgeries, fewer routine clinical visits, and the reallocation of medical resources toward pandemic response. Manufacturing and distribution networks also experienced disruptions because of transportation restrictions and supply-chain challenges. Nevertheless, wound care remained necessary for chronic conditions, injuries, and patients requiring continued treatment. Growing use of telemedicine and home healthcare created additional methods for wound monitoring and management, helping the market recover progressively as healthcare facilities restored regular services.
The advanced wound dressings segment is expected to be the largest during the forecast period
The advanced wound dressings segment is expected to account for the largest market share during the forecast period because they offer versatile solutions for managing different types of wounds and clinical requirements. Their functions include maintaining appropriate moisture levels, controlling wound fluid, reducing infection risks, and supporting tissue repair. These dressings are widely utilized for chronic and surgical wounds, burns, diabetic ulcers, and pressure injuries. A broad range of specialized formats, combined with ongoing technological improvements, supports their continued use across hospitals, outpatient facilities, and home-based wound care environments.
The home healthcare segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate as wound management increasingly shifts toward convenient and patient-focused treatment at home. Rising chronic wound prevalence, population aging, reduced hospital stays, and the need for economical care are supporting this transition. Advanced wound dressings enable effective home treatment through moisture regulation, exudate control, infection protection, and healing support. Additionally, wider adoption of telehealth services and remote monitoring technologies is improving clinical supervision, creating favorable conditions for greater use of advanced wound care products in home healthcare.
During the forecast period, the North America region is expected to hold the largest market share because of its developed healthcare systems, widespread use of innovative medical solutions, and considerable need for chronic wound treatment. The region experiences substantial demand associated with diabetes, vascular disorders, pressure injuries, and other complex wounds. Broad access to specialized wound-care facilities, advanced therapies, and established treatment practices strengthens adoption. Published research identifies North America as the largest regional market for advanced wound-care products and technologies worldwide.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving healthcare systems, increased surgical procedures, rising chronic wound cases, and greater healthcare investment. Markets such as China, India, and Japan are supporting regional development through better healthcare accessibility and increasing utilization of advanced wound treatment solutions. Population aging and the growing prevalence of chronic illnesses are further creating demand for specialized products. Continued technological innovation is also helping expand the adoption of advanced wound care technologies throughout the region.
Key players in the market
Some of the key players in Wound Care & Advanced Dressing Technologies Market include Smith+Nephew, Molnlycke Health Care, ConvaTec Group, Coloplast, Solventum, Medline Industries, Cardinal Health, Integra LifeSciences, B. Braun, PAUL HARTMANN, Advanced Medical Solutions, Lohmann & Rauscher, Urgo Medical, Organogenesis, MiMedx Group, DeRoyal Industries, Winner Medical and Hollister Incorporated.
In June 2025, Smith+Nephew announce a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint repair and replacement technology for conditions such as rotator cuff repair, ACL reconstruction, knee and hip replacements, and foot & ankle/hand & wrist procedures.
In March 2025, Convatec is excited to announce its global collaboration with the Wound, Ostomy, and Continence Nurses Society(TM) (WOCN(R)), the largest and most recognised professional nursing community dedicated to advancing the practice and delivery of expert healthcare to individuals with wound, ostomy, and continence care needs.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.